These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 180849)
21. Effects of neuromuscular blocking agents on arterial blood pressure in the rat. Jiffry MT Indian J Physiol Pharmacol; 1979; 23(2):133-6. PubMed ID: 489095 [TBL] [Abstract][Full Text] [Related]
22. Pharmacology and clinical use of neuromuscular blocking agents. DeGarmo BH; Dronen S Ann Emerg Med; 1983 Jan; 12(1):48-55. PubMed ID: 6295218 [No Abstract] [Full Text] [Related]
23. The clinical use of muscle relaxants. Foldes FF Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585 [No Abstract] [Full Text] [Related]
24. The potentiation of neuromuscular blocking agents by quinidine. Miller RD; Way WL; Katzung BG Anesthesiology; 1967; 28(6):1036-41. PubMed ID: 4383426 [No Abstract] [Full Text] [Related]
25. Relative potency of some neuromuscular blocking drugs in vivo and in vitro. Anttila P; Ertama P Med Biol; 1978 Jun; 56(3):152-5. PubMed ID: 682698 [TBL] [Abstract][Full Text] [Related]
26. Assessment of neuromuscular blockade using tetanic, single-twitch and train-of-four responses: discussion paper. Hughes R J R Soc Med; 1984 May; 77(5):399-405. PubMed ID: 6547184 [No Abstract] [Full Text] [Related]
27. The effect of alkalosis on the action of the neuromuscular blocking agents. KATZ RL; NGAI SH; PAPPER EM Anesthesiology; 1963; 24():18-22. PubMed ID: 14031326 [No Abstract] [Full Text] [Related]
28. Influence of gallamine, pancuronium, d-tubocurarine and succinylcholine on adrenergic neurotransmission. Vercruysse P; Bossuyt P; Verbeuren TJ; Vanhoutte PM; Hanegreefs G Acta Anaesthesiol Belg; 1979; 30 Suppl():71-8. PubMed ID: 232807 [TBL] [Abstract][Full Text] [Related]
30. Classification of neuromuscular blocking agents in a new neuromuscular preparation of the chick in vitro. van Riezen H Eur J Pharmacol; 1968 Dec; 5(1):29-36. PubMed ID: 5718516 [No Abstract] [Full Text] [Related]
32. Dose-response curves for four neuromuscular blockers using continuous i.v. infusion. Shanks CA; Walker JS; Ramzan MI; Triggs EJ Br J Anaesth; 1981 Jun; 53(6):627-33. PubMed ID: 7248126 [TBL] [Abstract][Full Text] [Related]
33. [Molecular theory about the mechanism of action of curare compounds]. Waser PG Anaesthesist; 1971 Jan; 20(1):23-9. PubMed ID: 4251063 [No Abstract] [Full Text] [Related]
34. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine. Miller RD; Larson CP; Way WL Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447 [No Abstract] [Full Text] [Related]
35. Experimental study on the neuromuscular blocking action of procaine amide. Galzigna L; Manani G; Mammano S; Gasparetto A; Deana R Agressologie; 1972; 13(2):107-16. PubMed ID: 4342790 [No Abstract] [Full Text] [Related]
36. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Waud BE; Waud DR Anesthesiology; 1971 Nov; 35(5):456-64. PubMed ID: 4329144 [No Abstract] [Full Text] [Related]
37. [Electromyographic studies of the supposed interference of Trasylol in neuromuscular block induced with curariform drugs]. Manani G; Gritti G; Vecchini L; Manzin E; Merli GA Acta Anaesthesiol; 1968; 19():Suppl 9:1-21. PubMed ID: 4247861 [No Abstract] [Full Text] [Related]
38. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission. Lu TC J Pharmacol Exp Ther; 1970 Sep; 174(3):560-6. PubMed ID: 4247938 [No Abstract] [Full Text] [Related]
39. Ketamine interaction with neuromuscular blocking agents in the phrenic nerve-hemidiaphragm preparation of the rat. Amaki Y; Nagashima H; Radnay PA; Foldes FF Anesth Analg; 1978; 57(2):238-43. PubMed ID: 565162 [No Abstract] [Full Text] [Related]